Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) Return on Equity (2016 - 2025)

Bio-Techne has reported Return on Equity over the past 16 years, most recently at 0.0% for Q4 2025.

  • Quarterly results put Return on Equity at 0.0% for Q4 2025, down 7.0% from a year ago — trailing twelve months through Dec 2025 was 0.0% (down 7.0% YoY), and the annual figure for FY2025 was 0.01%, down 8.0%.
  • Return on Equity for Q4 2025 was 0.0% at Bio-Techne, up from 0.0% in the prior quarter.
  • Over the last five years, Return on Equity for TECH hit a ceiling of 0.13% in Q2 2023 and a floor of 0.04% in Q1 2021.
  • Median Return on Equity over the past 5 years was 0.06% (2021), compared with a mean of 0.05%.
  • Biggest five-year swings in Return on Equity: dropped -14bps in 2021 and later grew 13bps in 2023.
  • Bio-Techne's Return on Equity stood at 0.07% in 2021, then plummeted by -95bps to 0.0% in 2022, then skyrocketed by 2528bps to 0.1% in 2023, then dropped by -29bps to 0.07% in 2024, then crashed by -104bps to 0.0% in 2025.
  • The last three reported values for Return on Equity were 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.01% (Q2 2025) per Business Quant data.